Cancer patients have a significantly higher risk of COVID-19 infection compared to those without cancer, especially those undergoing treatment for blood and lung cancers. These patients face higher mortality rates, and the pandemic has led to delays or cancellations of treatments.
Sub-Sessions:
Related Tags: Telemedicine | Impact on Cancer Services | Vaccination for Cancer Patients | Mental Health During COVID-19 | Care Disruptions | Patient Safety | Remote Patient Monitoring | Healthcare Access | Survivorship | Public Health Guidelines | Cancer Research | Impact on Clinical Trials | Cancer Treatment Delays | Patient Support | Psychosocial Impact
Related Societies: American Cancer Society | National Cancer Institute | European Society for Medical Oncology - COVID-19 Impact Task Force | World Health Organization - COVID-19 and Cancer Care Guidelines | Children with Cancer UK